Reports and Releases
FIT Biotech Oy: FIT Biotech withdraws a patent application
FIT Biotech Oy
Company release 13.9.2018 klo 3:45 PM EET
FIT Biotech withdraws a patent application
FIT Biotech Ltd ("Company", FITBIO: FN Finland) announced on 23rd of May 2018 that it filed two international patent applications. For strategic reasons, the board of directors of the company has decided to withdraw one of these applications before it is published. The withdrawn application relates to a further developed technology platform.
CEO Erkki Pekkarinen comments: "The patent application would have brought public such research results we want to keep private for strategic reasons."
The company still has a pending patent application for the use of the company's technology in the treatment of cancer. The application is very important as the company continues to commercialize gene-based therapies.
FIT BIOTECH OY
Board of Directors